Jump to Main Content

Highlights of ASH in North America

Join global hematology leaders at Highlights of ASH in North America, a two-day program offered in multiple locations, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.

Highlights of ASH in North America




“Connecting with colleagues outside my particular area of focus within hematology has been very rewarding. Highlights of ASH is a great place to break out of my comfort zone and keep me up to date on the exciting advances in our field.”

Tyler W. Buckner, MD, MSc / University of Colorado School of Medicine
HOA_Speaker
HOA_NA_Meeting

Cutting-edge Research from Across Disciplines

Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.

 

Instant Insights

Ask questions and get feedback from top hematology experts in real time.

 

Real Advice You Can Use

Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.

 

Meet Experts in Your Field

Network with colleagues of all career stages and form connections in your field.

 

Earn CME credits

Attendees can earn continuing medical education (CME) credits for physicians, while non-physicians and other health care professionals may receive a Certificate of Completion.

Meeting Information





Program Schedule

This program is curated for hematologists, oncologists, fellows and trainees, allied health professionals, advanced practice providers, and hematopathologists. The following session topics correspond to the 2027 Highlights of ASH in North America and are subject to change. The program schedule is identical for all 2027 Highlights of ASH North America locations.

11:00 a.m. Registration and Exhibits Open (Lunch provided)
11:45 a.m. Welcome and Introductions
12:00 p.m. Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Chronic Myeloid Leukemia
Kelly Chien, MD
The University of Texas MD Anderson Cancer Center
Seattle
Aaron T. Gerds, MD, MS
Cleveland Clinic and Case Comprehensive Cancer Center
New York
Naveen Pemmaraju, MD
The University of Texas MD Anderson Cancer Center
Chicago
Katherine Walsh, MD
Vanderbilt University Medical Center
Washington, DC
12:45 p.m. Indolent Lymphoma and Chronic Lymphocytic Leukemia
Matthew Cortese, MD, MPH
Roswell Park Comprehensive Cancer Center
New York
Matthew Kang, MD, FRCPC
Joseph Brant Hospital
Chicago & Washington, DC
Krish Patel, MD
Sarah Cannon Research Institute
Seattle
1:30 p.m. Aggressive Lymphoma
Jeremy Abramson, MD, MMSc
Mass General Brigham Cancer Institute
New York
Manali Kamdar, MD
University of Colorado
Seattle
Yasmin Karimi, MD
University of Michigan
Washington, DC
Peter Riedell, MD
University of Chicago
Chicago
2:15 p.m. Panel Discussion
2:45 p.m. Coffee Break and Exhibits Open
3:00 p.m. Bleeding Disorders
Mary Ann Knovich, MD
Wake Forest School of Medicine, Atrium Health Levine Cancer Institute
New York
Ming Y. Lim, MBBCh, MS
University of Utah
Seattle
Robert Klaassen, MD, FRCPC
Children's Hospital of Eastern Ontario
Chicago & Washington, DC
3:45 p.m. Thrombosis
Gloria Gerber, MD
Johns Hopkins University
Washington, DC
Damon Houghton, MD, MS
Mayo Clinic
Seattle
Alfred Lee, MD, PhD
Yale School of Medicine
Chicago
Rachel Rosovsky, MD, MPH
Massachusetts General Hospital
New York
4:30 p.m. Women’s Health and Iron
Jason Freed, MD
Harvard Medical School / Beth Israel Deaconess Medical Center
Washington, DC
Alecia Nero, MD, MSCS
UT Health Houston
Seattle
Layla Van Doren, MD, MBA
University of California, San Francisco
New York
Michelle Sholzberg, MDCM, FRCPC, MSc
St. Michael's Hospital, University of Toronto
Chicago
5:15 p.m. Panel Discussion
5:45 p.m. Highlights of ASH Day 1 Program Adjournment
7:00 a.m. Registration and Exhibits Open (Breakfast provided)
7:45 a.m. Welcome and Introductions
8:00 a.m. Plasma Cell Disorder & Myeloma
Jack Khouri, MD
Cleveland Clinic
Chicago
Martha Louzada, MD, MSCS
London Health Sciences Centre
Washington, DC
Jorge Monge, MD
University of Colorado Anschutz
Seattle
Ruben Niesvizky, MD
Weill Cornell Medicine
New York
8:45 a.m. Transplantation
Uday Deotare, MBBS, MD, MScHQ, DRCPSC
London Health Sciences Centre, Western University
Washington, DC
Hany Elmariah, MD, MS
Stanford University
Seattle
Mehdi Hamadani, MD
Medical College of Wisconsin
Chicago
Hannah Lust, MD
Ann & Robert H. Lurie Children's Hospital
New York
9:30 a.m. Complications of Novel Therapies
Nadine Abdallah, MD
Mayo Clinic
New York
Saurabh Dahiya, MD
Stanford University
Washington, DC
Loretta Nastoupil, MD
Southwest Oncology/Mercy CommonSpirit
Chicago & Seattle
10:15 a.m. Panel Discussion
10:45 a.m. Coffee Break and Exhibits Open
11:00 a.m. Acute Lymphoblastic Leukemia
Hannah Levavi, MD
Icahn School of Medicine, Mount Sinai Hospital
New York
John Molina, MD, EdM
Cleveland Clinic Taussig Cancer Institute
Seattle
Susan Rheingold, MD
Children's Hospital of Philadelphia
Chicago & Washington, DC
11:45 a.m. Acute Myeloid Leukemia
Bhavana Bhatnagar, DO
WVU Cancer Institute in Wheeling
Chicago & Seattle
Pinkal Desai, MD, MPH
Weill Cornell Medicine
New York
Alison Walker, MD, MPH, MBA
Moffitt Cancer Center
Washington, DC
12:30 p.m. Panel Discussion
1:00 p.m. Lunch with the Experts (All Speakers and Attendees)
2:15 p.m. Hemoglobinopathies and Red Blood Cell Disorders
Maureen Okam Achebe, MD, MPH
Brigham and Women's Hospital, Harvard Medical School
New York
Charity Oyedeji, MD, MHS
Duke University
Washington, DC
Venée Tubman, MD, MMSc
Texas Children's Hospital
Seattle
Omar Niss, MD
Cincinnati Children's Hospital Medical Center
Chicago
3:00 p.m. Consultative Hematology
Cyrus Hsia, MD, FRCPC
London Health Sciences Centre
Chicago
Siraj Mithoowani, MD, MHPE, FRCPC, FACP
McMaster University
Seattle
Srikanth Nagalla, MBBS, MS
Herbert Wertheim Cancer Institute, Baptist Health South Florida
New York & Washington, DC
3:45 p.m. Beyond the Acute Illness
Elizabeth O’Donnell, MD
Dana-Farber Cancer Institute
New York
Ryan Jacobs, MD
Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine
Seattle
Urvi Shah, MD, MS, DipABLM
Memorial Sloan Kettering Cancer Center
Chicago & Washington, DC
4:30 p.m. Panel Discussion
5:00 p.m. Closing Remarks and Adjournment

Acknowledgments

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, our State Society Partners, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America.

Highlights of ASH Steering Subcommittee

  • Alison Walker, MD, MBA, MPH, Chair, Moffitt Cancer Center
  • Maureen Okam Achebe, MD, MPH, Brigham and Women’s Hospital 
  • Jason Freed, MD, Beth Israel Deaconess Medical Center
  • Cyrus C. Hsia, MD, FRCPC, London Health Sciences Centre
  • Manali Kamdar, MD, University of Colorado
  • Mary Ann Knovich, MD, Atrium Health Levine Cancer Institute​
  • John C. Molina, MD, EdM, Cleveland Clinic
  • Ruben Niesvizky, MD, Weill Cornell Medicine
  • Rachel P. Rosovsky, MD, Massachusetts General Hospital
  • Eric Tse, MBBS, PhD, Hong Kong University
  • Robert Zeiser, MD, University of Freiburg